another thing that perplexes me is the continued buying at $1.89 - i had assumed that others were planning to hold out together with Maven, so much for that logic!
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025